EQUILLIUM INC (EQ)

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

Equillium to Present at the Stifel Healthcare Conference

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

Equillium Maintains Rights to Itolizumab Following Ono Partnership

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024

EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Equillium (NASDAQ:EQ) just reported results for the second quarter of 2024.Equi...

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

Equillium to Participate in Upcoming Investor Conferences

Equillium to be included in the Russell Microcap® Index

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

Equillium to Present at the Jefferies Global Healthcare Conference

Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q1 2024

EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Equillium (NASDAQ:EQ) just reported results for the first quarter of 2024.Equil...

Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023

EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Equillium (NASDAQ:EQ) just reported results for the fourth quarter of 2023.Equi...

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference